January 4, 2017 / 12:11 PM / 7 months ago

BRIEF-Redhill Biopharma to present the positive results of the first phase iii study with rhb-105 for h. Pylori infection

1 Min Read

Jan 4 (Reuters) - Redhill Biopharma Ltd :

* Redhill Biopharma to present the positive results of the first phase iii study with RHB-105 for h. Pylori infection at the innovations in gastroenterology 2017 symposium

* Confirmatory phase iii study with rhb-105 is planned to be initiated in first half of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below